There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides ...

Rosuvastatin (Crestor) is used to treat several types of high cholesterol and to prevent heart disease. Learn about side effects, warnings, dosage, and more.

Rosuvastatin calcium (Crestor; AstraZeneca), the seventh drug in the statin class, was approved by the US FDA in August 2003 for the reduction of cholesterol levels in patients with ...

Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney failure with replacement therapy, according to a study.Further, investigators found ...

Study assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic dyslipidemia.

Paris, France - Investigators assessing the effects of different statins on lipid profile in hypercholesterolemic patients with and without metabolic syndrome have found that rosuvastatin (Crestor ...

Among those assigned to rosuvastatin, the median LDL cholesterol level at 12 months was 55 mg per deciliter (1.4 mmol per liter) (interquartile range, 44 to 72 [1.1 to 1.9]), and the median high ...

Rosuvastatin/ezetimibe is available as a once-daily tablet with dosages of 5 mg/10 mg, 10 mg/10 mg, 20 mg/10 mg and 40 mg/10 mg, according to the release. Warnings and precautions of rosuvastatin ...

Rosuvastatin reduced the number of hospitalizations for cardiovascular causes (154 fewer admissions per 1000 patients treated for a median follow-up of 2.7 years) and, as a result, reduced the ...

Anticholesterol rosuvastatin not associated with reduced risk for fractures Date: December 1, 2014 Source: The JAMA Network Journals Summary: Treatment with the anticholesterol medicine ...

Review the side-effects of Rosuvastatin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority ...

Atorvastatin, known commercially as Lipitor, was first approved for lowering LDL cholesterol in 1996 and lost patent protection in 2011. Crestor, the brand name of rosuvastatin, was approved in 2003 ...